Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Worsening Asthma Outcomes in Australian Adults: A Comparison of Stratified Sample Surveys in 2012 and 2021.

The Medical journal of Australia·2026

Same author

In vitro comparison of aerosol deposition by albuterol pMDI using corrugated tubing versus a commercial spacer.

International journal of pharmaceutics·2026

Same author

Role of oral bacteria composition and functional gene profiles in respiratory diseases.

BMJ open respiratory research·2026

Same author

Genome-wide discovery reveals 30 loci for choroidal thickness and uncovers potential causal links with angle-closure glaucoma.

medRxiv : the preprint server for health sciences·2026

Same author

Antibiotic Use in the First 2 Years of Life Is Related to Longitudinal BMI Trajectories From 0 to 18 years: A Prospective Cohort Study.

Journal of obesity·2026

Same author

Reply: An index of maximal expiratory flow-volume curve with different features related to central and peripheral concavity.

ERJ open research·2026

Search research articles

Related Experiment Video

Updated: Jul 5, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

COPD in Never-Smokers: BOLD Australia Study.

Marsha A Ivey^1,2, Sheree M Smith^3,4, Geza Benke¹

¹School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia.

International Journal of Chronic Obstructive Pulmonary Disease

|January 22, 2024

Summary

This summary is machine-generated.

Chronic Obstructive Pulmonary Disease (COPD) affects 10.5% of never-smokers in Australia. Key risk factors include older age, lower education, asthma history, childhood respiratory issues, and family history, underscoring non-smoking influences.

Keywords:

BOLD LLN burden of obstructive lung disease lower limit of normal non-smokers prevalence spirometry

More Related Videos

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

Related Experiment Videos

Last Updated: Jul 5, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

Area of Science:

Pulmonary Medicine
Epidemiology
Respiratory Health

Background:

Tobacco smoking is the primary risk factor for Chronic Obstructive Pulmonary Disease (COPD).
Risk factors for COPD in never-smokers are often overlooked, despite their significance.
Understanding these factors is crucial for comprehensive COPD management and prevention strategies.

Purpose of the Study:

To determine the prevalence of COPD among adults who have never smoked in Australia.
To identify specific risk factors associated with COPD development in this non-smoking population.

Main Methods:

Utilized data from the Australia Burden of Obstructive Lung Disease (BOLD) study.
Included participants aged 40 years and older from six Australian sites.
COPD was diagnosed using post-bronchodilator spirometry, defined by FEV1/FVC ratio <0.70 or below the lower limit of normal (LLN).

Main Results:

The prevalence of COPD in never-smokers (n=1656) was 10.5% (95% CI: 9.1-12.1%); 4.6% met the LLN criteria.
Increased likelihood of COPD was associated with advancing age, lower educational attainment (≤12 years), a history of asthma, childhood hospitalization for breathing problems before age 10, and a family history of respiratory diseases.
Being overweight or obese was linked to a reduced prevalence of COPD.

Conclusions:

COPD is a significant health issue among never-smokers aged 40 and above in Australia.
Factors beyond smoking, including age, education, medical history, and genetics, play a critical role in COPD development.
Highlights the need to consider diverse risk factors in COPD diagnosis and prevention for all populations.